Curr Pharm Des. 2007;13(3):287-312.

Recent advances in serine protease inhibitors as anticoagulant agents.

Prezelj A, Anderluh PS, Peternel L, Urleb U.

Source

Lek Pharmaceuticals d.d., Drug Discovery, Ljubljana, Slovenia.

Abstract

The drawbacks and limitations of existing anticoagulant therapy which may result in serious adverse effects and a high mortality rate, have given rise to many anticoagulant development programmes in the last decade, focusing mainly at development of thrombin and FXa low-molecular weight inhibitors. A detailed understanding of blood coagulation pathways, functioning of the serine proteases thrombin, FXa, FVIIa and FIXa and elucidation of their crystal structures resulted in many potent compounds, among which some have entered the clinical phase or have been approved for use in clinical practice. Recently, the focus of anticoagulant research turned to inhibition of the TF:FVIIa complex, with some promising clinical candidates on the horizon. This article provides an overview of the current development status of serine protease inhibitors as anticoagulants, including new trends such as dual coagulation factor inhibitors.

PMID:: 17313362; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

IndexCopernicus

Medical

Blood Thinners - MedlinePlus Health Information

Supplemental Content

Icon for Bentham Science Publishers Ltd.

Save items

Related citations in PubMed

Review Dual inhibitors of the blood coagulation enzymes. [Curr Med Chem. 2004]
Review Dual inhibitors of the blood coagulation enzymes.
Kranjc A, Kikelj D. Curr Med Chem. 2004 Oct; 11(19):2535-47.
Hemextin AB complex, a unique anticoagulant protein complex from Hemachatus haemachatus (African Ringhals cobra) venom that inhibits clot initiation and factor VIIa activity. [J Biol Chem. 2005]
Hemextin AB complex, a unique anticoagulant protein complex from Hemachatus haemachatus (African Ringhals cobra) venom that inhibits clot initiation and factor VIIa activity.
Banerjee Y, Mizuguchi J, Iwanaga S, Kini RM. J Biol Chem. 2005 Dec 30; 280(52):42601-11. Epub 2005 Oct 4.
Review Modulators of the coagulation cascade: focus and recent advances in inhibitors of tissue factor, factor VIIa and their complex. [Curr Med Chem. 2005]
Review Modulators of the coagulation cascade: focus and recent advances in inhibitors of tissue factor, factor VIIa and their complex.
Frédérick R, Pochet L, Charlier C, Masereel B. Curr Med Chem. 2005; 12(4):397-417.
Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination. [Bioorg Med Chem Lett. 2008]
Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination.
Shiraishi T, Kadono S, Haramura M, Kodama H, Ono Y, Iikura H, Esaki T, Koga T, Hattori K, Watanabe Y, et al. Bioorg Med Chem Lett. 2008 Aug 15; 18(16):4533-7. Epub 2008 Jul 16.
Mechanism-based isocoumarin inhibitors for blood coagulation serine proteases. Effect of the 7-substituent in 7-amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on inhibitory and anticoagulant potency. [J Med Chem. 1994]
Mechanism-based isocoumarin inhibitors for blood coagulation serine proteases. Effect of the 7-substituent in 7-amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on inhibitory and anticoagulant potency.
Kam CM, Kerrigan JE, Plaskon RR, Duffy EJ, Lollar P, Suddath FL, Powers JC. J Med Chem. 1994 Apr 29; 37(9):1298-306.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Recent advances in serine protease inhibitors as anticoagulant agents.
Recent advances in serine protease inhibitors as anticoagulant agents.
Curr Pharm Des. 2007 ;13(3):287-312.

PubMed
Possible influences on the expression of X chromosome-linked dystrophin abnormal...
Possible influences on the expression of X chromosome-linked dystrophin abnormalities by heterozygosity for autosomal recessive Fukuyama congenital muscular dystrophy.
Proc Natl Acad Sci U S A. 1992 Jan 15 ;89(2):623-7.

PubMed
Cervical surgery and preterm birth.
Cervical surgery and preterm birth.
J Perinat Med. 2007 ;35(1):5-9.

PubMed
The physiological effects of caffeine in women during treadmill walking.
The physiological effects of caffeine in women during treadmill walking.
J Strength Cond Res. 2007 Feb ;21(1):164-8.

PubMed
Characterization of a prototype strain of hepatitis E virus.
Characterization of a prototype strain of hepatitis E virus.
Proc Natl Acad Sci U S A. 1992 Jan 15 ;89(2):559-63.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Recent advances in serine protease inhibitors as anticoagulant agents.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information